Literature DB >> 15523318

Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy.

Manuel Pan1, José Suárez de Lezo, Alfonso Medina, Miguel Romero, José Segura, Djordje Pavlovic, Antonio Delgado, Soledad Ojeda, Francisco Melián, Juan Herrador, Isabel Ureña, Luis Burgos.   

Abstract

BACKGROUND: Rapamycin-eluting stents (RES) have been shown to reduce restenosis in many types of lesions. However, the ideal strategy for the treatment of coronary bifurcated lesions has not been established to date. This randomized study compares 2 strategies for the RES treatment of bifurcation lesions: a simple approach (stenting the main vessel and balloon dilatation for the side branch [SB]) versus a complex approach (stents for both vessels).
METHODS: To compare both strategies, a randomized study was conducted in 91 patients with true coronary bifurcation lesions. All patients received an RES at the main vessel, covering the SB. Patients from group A (n = 47) were assigned to balloon dilation of the involved SB (simple strategy); patients in group B (n = 44) were randomized to receive a second stent at the SB origin (complex strategy). There were no differences between groups regarding baseline clinical and angiographic data.
RESULTS: Major adverse cardiac events occurred in 3 patients from group A (2 non-Q-wave myocardial infarctions and 1 target lesion revascularization). Six-month angiographic reevaluation was obtained in 80 patients (88%). Restenosis of the main vessel was observed in 1 (2%) patient from group A and in 4 (10%) from group B. Restenosis of the SB appeared in 2 (5%) patients from group A and in 6 (15%) from group B.
CONCLUSIONS: Both strategies are effective in reducing the restenosis rate, with no differences in terms of clinical outcome. Elective SB stenting seems to provide no advantages over the simpler stent jail followed by SB balloon dilation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15523318     DOI: 10.1016/j.ahj.2004.05.029

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  32 in total

1.  Treatment of bifurcation lesions with two stents: one year angiographic and clinical follow up of crush versus T stenting.

Authors:  L Ge; I Iakovou; J Cosgrave; P Agostoni; F Airoldi; G M Sangiorgi; I Michev; A Chieffo; M Montorfano; M Carlino; N Corvaja; A Colombo
Journal:  Heart       Date:  2005-06-17       Impact factor: 5.994

2.  Utility of drug-eluting stents in complex lesions and high-risk patients.

Authors:  Eugenia Nikolsky; Gregg W Stone
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-02

3.  Evaluation of the dedicated Frontier coronary bifurcation stent: A matched pair analysis with drug-eluting and bare metal stents.

Authors:  Peter W Radke; Deepak Jain; Anja Conrad; Christina Thomsen; Marko Remmel; Volkhard Kurowski; Heribert Schunkert; Franz Hartmann
Journal:  Clin Res Cardiol       Date:  2007-11-28       Impact factor: 5.460

Review 4.  Dedicated bifurcation stents.

Authors:  Ajith Ananthakrishna Pillai; Balachander Jayaraman
Journal:  Indian Heart J       Date:  2012-04-28

Review 5.  Bifurcation lesion morphology and intravascular ultrasound assessment.

Authors:  Ricardo A Costa; Marco A Costa; Issam D Moussa
Journal:  Int J Cardiovasc Imaging       Date:  2011-03-17       Impact factor: 2.357

Review 6.  Percutaneous Coronary Intervention for Bifurcation: How Can We Outperform the Provisional Strategy?

Authors:  Andrew Kei-Yan Ng; Man-Hong Jim
Journal:  Clin Cardiol       Date:  2016-08-24       Impact factor: 2.882

Review 7.  Recent perspective on coronary artery bifurcation interventions.

Authors:  Debabrata Dash
Journal:  Heart Asia       Date:  2014-02-14

8.  A Pilot Study on Culottes versus Crossover Single Stenting for True Coronary Bifurcation Lesions.

Authors:  Linlin Zhang; Wenliang Zhong; Yukun Luo; Lianglong Chen
Journal:  Acta Cardiol Sin       Date:  2016-07       Impact factor: 2.672

9.  Personal Experience with Bioresorbable Scaffolds in Bifurcations.

Authors:  Roberto Diletti; Nicolas M Van Mieghem
Journal:  Interv Cardiol       Date:  2013-08

Review 10.  Drug eluting stents: an updated meta-analysis of randomised controlled trials.

Authors:  C Roiron; P Sanchez; A Bouzamondo; P Lechat; G Montalescot
Journal:  Heart       Date:  2005-10-10       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.